Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis

Bodil Petersen, Klaus Bendtzen, Nils Koch-Henriksen, Mads Ravnborg, Christian Ross, Per Soelberg Sorensen, Danish Multiple Sclerosis Group

    41 Citationer (Scopus)

    Abstract

    The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.
    OriginalsprogEngelsk
    TidsskriftMultiple Sclerosis
    Vol/bind12
    Udgave nummer3
    Sider (fra-til)247-52
    Antal sider6
    ISSN1352-4585
    StatusUdgivet - 1 jun. 2006

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis'. Sammen danner de et unikt fingeraftryk.

    Citationsformater